Bohanon Amanda L, Browning Luke S, Sammons Rae M, Piserchio Andrea, Tavares Clint D J, Cho Eun Jeong, Ghose Ranajeet, Dalby Kevin N
Interdisciplinary Life Sciences Graduate Program, the University of Texas, Austin, TX, 78712.
Targeted Therapeutic Drug Discovery and Development Program, the University of Texas, Austin, TX, 78712.
bioRxiv. 2025 Jul 1:2025.06.30.662482. doi: 10.1101/2025.06.30.662482.
Eukaryotic elongation factor-2 kinase (eEF-2K), a member of the α-kinase family of atypical kinases, phosphorylates eukaryotic elongation factor 2 (eEF-2), thereby inhibiting ribosomal translocation and downregulating translational elongation in response to diverse cellular cues. eEF-2K is activated by Ca/calmodulin (CaM) and integrates upstream inputs from diverse signaling pathways, including PKA and mTOR, which target regulatory sites on a disordered regulatory loop. Among these, serine 500 (S500) has been identified as a key phosphorylation site targeted by both eEF-2K and PKA. However, the influence of this post-translational modification on the properties of eEF-2K has remained unclear. Prior studies have shown that S500 phosphorylation accelerates autophosphorylation of eEF-2K at its primary activating site, threonine 348 (T348). Here, we demonstrate that S500 phosphorylation, mimicked by a S500D mutation, works in conjunction with T348 phosphorylation to enhance the intrinsic (CaM-independent) activity of eEF-2K. Hydrogen-deuterium exchange mass spectrometry reveals that CaM binding, and consequent enhancement in eEF-2K activity, is accompanied by conformational changes proximal to S500. Deletion of S500 and surrounding residues mimics the effects of S500D, promoting robust CaM-independent activity. These data suggest that CaM binding or S500 phosphorylation have similar effects, likely relieving an inhibitory constraint to enhance activity. Further, S500 phosphorylation enhances binding to both apo-CaM and Ca/CaM, suggesting a mechanism for maintaining basal activity and priming the kinase for rapid reactivation in response to Ca transients. These findings support a model in which phosphorylation on T348 and S500 synergize to stabilize the active conformation of eEF-2K.
真核生物延伸因子2激酶(eEF - 2K)是非典型激酶α激酶家族的成员,它使真核生物延伸因子2(eEF - 2)磷酸化,从而抑制核糖体转位并响应多种细胞信号下调翻译延伸。eEF - 2K被钙/钙调蛋白(CaM)激活,并整合来自多种信号通路的上游输入,包括蛋白激酶A(PKA)和雷帕霉素靶蛋白(mTOR),这些信号通路作用于一个无序调节环上的调节位点。其中,丝氨酸500(S500)已被确定为eEF - 2K和PKA共同作用的关键磷酸化位点。然而,这种翻译后修饰对eEF - 2K特性的影响仍不清楚。先前的研究表明,S500磷酸化会加速eEF - 2K在其主要激活位点苏氨酸348(T348)处的自身磷酸化。在这里,我们证明由S500D突变模拟的S500磷酸化与T348磷酸化协同作用,增强了eEF - 2K的内在(不依赖CaM)活性。氢氘交换质谱分析表明,CaM结合以及随之而来的eEF - 2K活性增强伴随着S500附近的构象变化。删除S500及其周围残基模拟了S500D的作用,促进了强大的不依赖CaM的活性。这些数据表明,CaM结合或S500磷酸化具有相似的作用,可能是解除了一种抑制性限制以增强活性。此外,S500磷酸化增强了与脱辅基CaM和Ca/CaM的结合,这表明了一种维持基础活性并使激酶在响应钙瞬变时快速重新激活的机制。这些发现支持了一个模型,即T348和S500上的磷酸化协同作用以稳定eEF - 2K的活性构象。